Merck Pulls Tredaptive Cholesterol Pill After A Flop

By Ed Silverman Less than a month after a study showed its Tredaptive cholesterol pill failed to prevent heart attacks, strokes and deaths more than traditional statin drugs that lower ...

FDA Does About Face On Research Misconduct Rule

 By Ed Silverman Last summer, the FDA proposed a new rule designed to tighten the dissemination of information related to investigations into research misconduct by individuals, including ...

South Korean Drug Execs Indicted For Kickbacks

By Ed Silverman Several current and former execs at Dong-A Pharmaceutical, which is the largest drugmaker in South Korea, were indicted yesterday for providing roughly $500,000 in kickbacks ...

UPDATED: Biotech upstart revives cancer drug from Pfizer with $15.5M round

By Ryan McBride Another biotech startup is picking up where Pfizer left off with an experimental drug. Esanex wrapped up a $15.5 million round of financing last month and plans to ...

Regeneron exec tops list of highest-paid biotech R&D officers

By Emily Mullin It’s a good time to be a biotech R&D boss. Emerging from the global financial downturn, the biotech industry has roared back with record market values and ...

ArQule, Daiichi cough up another failure for lead cancer drug

By Ryan McBride ArQule ($ARQL) suffered another failure with its top anti-cancer contender tivantinib. This time the experimental kinase inhibitor fell short in a midstage study in ...

J&J’s diabetes drug passes FDA panel test despite safety concerns

By Ryan McBride Johnson & Johnson emerged from a showdown with FDA advisers with some scratches but ultimately a win on Thursday. An agency advisory committee backed approval of ...

GSK rests hopes on R&D pipeline after tough 2012

By Ryan McBride GlaxoSmithKline ($GSK) faces some major regulatory decisions this year that will shape the future of the drug giant for years to come. And Bloomberg took the pulse ...

Dako teams up with Eli Lilly for companion diagnostics

By Damian Garde Dako, now owned by Agilent Technologies ($A), has signed a deal with Eli Lilly ($LLY) to develop companion diagnostics for the drugmaker’s pipeline cancer treatments. Under ...

Covidien closes drug-coated balloon buyout

By Damian Garde Covidien ($COV) has wrapped up its acquisition of startup CV Ingenuity, snagging the rights to the company’s in-development drug-coated balloon designed to ...

Researchers successfully divine lung infection Dx data from breath

By Mark Hollmer University of Vermont scientists are making headway on developing a diagnostic that could analyze a person’s breath to diagnose different types of lung bacteria. The BBC reports ...

Medtronic hunts for expanded pacer indication with large study

By Damian Garde Medtronic ($MDT) has its eye on expanding the use of cardiac resynchronization therapy pacemakers (CRT-Ps), looking to test the devices in up to 2,300 patients with mildly ...
Page 3 of 7212345...102030...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS